Stephanie Gu

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients”.

PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients

Supportive Care in Cancer(2023)10.1007/s00520-023-07793-5

N/A

0.269DataRank · unranked

5 citations

Christian Menzer, Jennifer L. Hay, Camila Peña, Stephen W. Dusza, Mario E. Lacouture +2 more

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07143-3

N/A

0.241DataRank · unranked

4 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Management of immune-related cutaneous adverse events with dupilumab

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007324

N/A

0DataRank · unranked

51 citations

Stephanie Gu, Joseph R. Stoll, Andrea P. Moy, Stephen W. Dusza, Allison Gordon +8 more

Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab

Leukemia & lymphoma/Leukemia and lymphoma(2023)10.1080/10428194.2023.2221756

N/A

0DataRank · unranked

4 citations

Emily A. Cowen, Stephanie Gu, Stephen W. Dusza, Melissa Pulitzer, Mark B. Geyer +3 more

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients

Research Square(2023)10.21203/rs.3.rs-2679676/v1

N/A

0DataRank · unranked

0 citations

Stephen W. Dusza, Elizabeth Quigley, Helen Haliasos, Alina Markova, Michael A. Marchetti +7 more

Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3431

N/A

0DataRank · unranked

32 citations

Elena Goleva, Neil J. Shah, Veronica Rotemberg, Lukas Kraehenbuehl, Kwami F. Ketosugbo +15 more